BiotechTube
Home/Nanospectra Biosciences/Dr. Mark R. Hurwitz
DM

Dr. Mark R. Hurwitz

Chief Medical Officer

Nanospectra Biosciences

Therapeutic Areas

Oncology

Nanospectra Biosciences Pipeline

DrugIndicationPhase
AuroLase TherapyLocalized, low- to intermediate-risk Prostate CancerPhase 3

Leadership Team at Nanospectra Biosciences

DJ
David Jorden
CEO & President
DN
Dr. Naomi J. Halas
Scientific Co-Founder & Advisor
View full Nanospectra Biosciences profile